Techniques: Prostate-specific membrane antigen (PSMA; FOLH1; GCPII)-targeting PET imaging agent to detect prostate cancer

Imaging

TECHNOLOGY: PET

Phosphoramidate-based PSMA-targeting PET imaging agents could help detect prostate cancer. The two

Read the full 138 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE